n-acetylsphingosine has been researched along with Insulin Resistance in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ali-Berrada, S; Bandet, CL; Blachnio-Zabielska, A; Campana, M; Ferré, P; Foufelle, F; Hajduch, E; Le Stunff, H; Pais-de-Barros, JP; Poirier, M; Rouch, C; Tan-Chen, S | 1 |
| Adeli, K; Baker, C; Dekker, MJ; Naples, M; Qiu, W; Sacco, J; Samsoondar, J; Zhang, R | 1 |
| Chiu, TT; Klip, A; Koshkina, A; Sun, Y | 1 |
| Chuang, JH; Hsieh, CT; Lin, Y; Yang, WC; Yin, Y | 1 |
| JeBailey, L; Klip, A; Niu, W; Roessler, J; Rudich, A; Wanono, O | 1 |
| Brindley, DN; Hanna, AN; Mei, J; Wang, CN; Xu, J | 1 |
| Brindley, D; Degerman, E; Holm, C; Holst, LS; Landström, TR; Manganiello, V; Mei, J | 1 |
| Brindley, DN; Hanna, AN; Xu, J | 1 |
8 other study(ies) available for n-acetylsphingosine and Insulin Resistance
| Article | Year |
|---|---|
Ceramide analog C2-cer induces a loss in insulin sensitivity in muscle cells through the salvage/recycling pathway.
Topics: Ceramides; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Resistance; Muscle Cells; Muscle, Skeletal | 2023 |
Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Topics: Animal Feed; Animals; Apolipoprotein B-100; Cricetinae; Dietary Fats; Disease Models, Animal; Dyslipidemias; Fatty Acids, Monounsaturated; Fructose; Glucose Intolerance; Hepatitis; Immunosuppressive Agents; Insulin Resistance; Lipoproteins, VLDL; Liver; Male; Mesocricetus; Signal Transduction; Sphingolipids; Sphingosine | 2013 |
Rac-1 superactivation triggers insulin-independent glucose transporter 4 (GLUT4) translocation that bypasses signaling defects exerted by c-Jun N-terminal kinase (JNK)- and ceramide-induced insulin resistance.
Topics: Animals; Cell Line; Cell Membrane; Cell Polarity; Enzyme Activation; Glucose Transporter Type 4; Guanine Nucleotide Exchange Factors; Humans; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphatidylinositols; Phosphorylation; Protein Multimerization; Protein Processing, Post-Translational; Protein Transport; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; Rats; Signal Transduction; Sphingosine; T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 2013 |
Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle.
Topics: Animals; Cell Line; Enzyme Activation; Glucose; HEK293 Cells; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Luciferases; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Monomeric GTP-Binding Proteins; Multiprotein Complexes; Muscle Fibers, Skeletal; Neuropeptides; Phosphorylation; Protein Kinase C-delta; Proto-Oncogene Proteins c-akt; Ras Homolog Enriched in Brain Protein; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; RNA, Small Interfering; Signal Transduction; Sirolimus; Sphingosine; TOR Serine-Threonine Kinases | 2014 |
Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells.
Topics: Actins; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Glucose Oxidase; Glucose Transporter Type 4; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Muscle Fibers, Skeletal; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Protein Transport; Proto-Oncogene Proteins c-akt; rac GTP-Binding Proteins; Receptor, Insulin; Sphingosine | 2007 |
Tumor necrosis factor-alpha and ceramides in insulin resistance.
Topics: 3T3 Cells; Adipocytes; Animals; Biological Transport; Ceramides; Deoxyglucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Kinetics; Mice; Monosaccharide Transport Proteins; Muscle Proteins; Phosphatidylinositol 3-Kinases; Phosphoproteins; Sphingosine; Tumor Necrosis Factor-alpha | 1999 |
C(2)-ceramide influences the expression and insulin-mediated regulation of cyclic nucleotide phosphodiesterase 3B and lipolysis in 3T3-L1 adipocytes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3T3 Cells; Adipocytes; Animals; Blotting, Western; Chromans; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Drug Interactions; Enzyme Inhibitors; Insulin; Insulin Resistance; Isoquinolines; Lipolysis; Mice; Receptors, Cytoplasmic and Nuclear; Sphingosine; Sulfonamides; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Necrosis Factor-alpha | 2002 |
Tumor necrosis factor-alpha, sphingomyelinase and ceramides activate tyrosine kinase, p21Ras and phosphatidylinositol 3-kinase: implications for glucose transport and insulin resistance.
Topics: Animals; Biological Transport; Ceramides; Enzyme Activation; Fibroblasts; Glucose; Insulin Resistance; Kinetics; Phosphatidylinositol 3-Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins p21(ras); Rats; Sphingomyelin Phosphodiesterase; Sphingosine; Tumor Necrosis Factor-alpha | 2001 |